We serve Chemical Name:3-Bromo-5-methylphenol CAS:74204-00-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-Bromo-5-methylphenol
CAS.NO:74204-00-5
Synonyms:QR CE E1;Phenol,3-bromo-5-methyl;3-methyl-5-bromophenol;5-bromo-3-methylphenol;5-bromo-3-hydroxytoluene;Phenol, 3-bromo-5-methyl-;3-Bromo-5-methylphenol;1-bromo-3-hydroxy-5-methylbenzene;5-Bromo-m-cresol;3-Brom-5-methyl-phenol
Molecular Formula:C7H7BrO
Molecular Weight:187.034
HS Code:2908199090
Physical and Chemical Properties:
Melting point:61-62ºC
Boiling point:249.3±20.0 °C at 760 mmHg
Density:1.6±0.1 g/cm3
Index of Refraction:1.591
PSA:20.23000
Exact Mass:185.968018
LogP:3.09
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like QR CE E1 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Brom-5-methyl-phenol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-bromo-3-hydroxy-5-methylbenzene Use and application,QR CE E1 technical grade,usp/ep/jp grade.
Related News: Myelodysplastic syndromes (MDS) are conditions that can occur when the blood-forming cells in the bone marrow become dysfunctional and thus produce an inadequate number of circulating blood cells. 3-Bromo-5-methylphenol manufacturer Prime Minister Scott Morrison said Saturday that all travelers from mainland China allowed into Australia had to be quarantined for 14 days. 3-Bromo-5-methylphenol supplier Right now, midstage data for Roche-AC Immune’s anti-tau antibody semorinemab in moderate Alzheimer’s are expected later this year, but it has already failed a phase 2 study in mild disease. 3-Bromo-5-methylphenol vendor Prime Minister Scott Morrison said Saturday that all travelers from mainland China allowed into Australia had to be quarantined for 14 days. 3-Bromo-5-methylphenol factory Myelodysplastic syndromes (MDS) are conditions that can occur when the blood-forming cells in the bone marrow become dysfunctional and thus produce an inadequate number of circulating blood cells.
